MedTrace Logo

Circumferential Periareolar Mastopexy Using SERI Surgical Scaffold

NCT02293798 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2019-09-10

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the clinical performance of SERI® Surgical Scaffold to maintain the size of the areola by providing additional soft tissue support after circumferential periareolar mastopexy.

Conditions

  • Mastopexy

Interventions

DEVICE

silk surgical scaffold

surgical implant

Sponsors & Collaborators

  • Allergan

    collaborator INDUSTRY

  • Mark Mofid MD

    lead INDIV

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02293798 on ClinicalTrials.gov